{"DataElement":{"publicId":"7843548","version":"1","preferredName":"Laboratory Measurement Test or Examination Detail Sponsor Defined Type","preferredDefinition":"The detail of the laboratory examination used to obtain the measurement or finding.","longName":"LBTSTDTL_SPD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"7843543","version":"1","preferredName":"Laboratory Data Domain Measurement Test or Examination Detail","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to laboratory data._Particulars considered individually and in relation to a measurement, test or examination.","longName":"6401816v1.0:6420439v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"6401816","version":"1","preferredName":"Laboratory Data Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to laboratory data.","longName":"C49592","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Data Domain","conceptCode":"C49592","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to laboratory data.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7393E896-CD8C-74C0-E053-F662850A1D4C","latestVersionIndicator":"Yes","beginDate":"2018-08-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-16","modifiedBy":"ONEDATA","dateModified":"2018-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6420439","version":"1","preferredName":"Measurement, Test or Examination Detail","preferredDefinition":"Particulars considered individually and in relation to a measurement, test or examination.","longName":"C117062","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurement, Test or Examination Detail","conceptCode":"C117062","definition":"Particulars considered individually and in relation to a measurement, test or examination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"746B6C02-A4E8-43B2-E053-F662850ACF55","latestVersionIndicator":"Yes","beginDate":"2018-08-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-08-27","modifiedBy":"ONEDATA","dateModified":"2018-08-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D18D8508-F13E-673F-E053-4EBD850A9F85","latestVersionIndicator":"Yes","beginDate":"2021-11-24","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-24","modifiedBy":"SOKKERL","dateModified":"2022-06-13","changeDescription":"11/24/2021 created for IFA form, wz.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7843545","version":"1","preferredName":"Measurement Test or Examination Detail Clinical Study Sponsor Defined Type","preferredDefinition":"Particulars considered individually and in relation to a measurement, test or examination._An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]_Clearly characterized or delimited._Something distinguishable as an identifiable class based on common qualities.","longName":"LBTSTDTL_SPD","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"%Pos","valueDescription":"Positive Cell Percentage","ValueMeaning":{"publicId":"7843546","version":"1","preferredName":"Positive Cell Percentage","longName":"7843546","preferredDefinition":"Involving advantage or good.: The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.: A fraction or ratio with 100 understood as the denominator.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive","conceptCode":"C25246","definition":"Involving advantage or good.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Cell","conceptCode":"C12508","definition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D18DC466-3AF6-6745-E053-4EBD850AEA72","latestVersionIndicator":"Yes","beginDate":"2021-11-24","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-24","modifiedBy":"ONEDATA","dateModified":"2021-11-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D18DC466-3B11-6745-E053-4EBD850AEA72","beginDate":"2021-11-24","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-24","modifiedBy":"ONEDATA","dateModified":"2021-11-24","deletedIndicator":"No"},{"value":"%NAP","valueDescription":"Nuclear Area Positive Percentage","ValueMeaning":{"publicId":"7843547","version":"1","preferredName":"Nuclear Area Positive Percentage","longName":"7843547","preferredDefinition":"Pertaining to the nucleus.: The extent of a 2-dimensional surface enclosed within a boundary.: Involving advantage or good.: A fraction or ratio with 100 understood as the denominator.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nuclear","conceptCode":"C13361","definition":"Pertaining to the nucleus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Area","conceptCode":"C25244","definition":"The extent of a 2-dimensional surface enclosed within a boundary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Positive","conceptCode":"C25246","definition":"Involving advantage or good.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D18DC466-3B20-6745-E053-4EBD850AEA72","latestVersionIndicator":"Yes","beginDate":"2021-11-24","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-24","modifiedBy":"ONEDATA","dateModified":"2021-11-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D18DC466-3B3B-6745-E053-4EBD850AEA72","beginDate":"2021-11-24","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-24","modifiedBy":"ONEDATA","dateModified":"2021-11-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7843544","version":"1","preferredName":"Measurement, Test or Examination Detail Clinical Study Sponsor Defined Type","preferredDefinition":"Particulars considered individually and in relation to a measurement, test or examination.:An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]:Clearly characterized or delimited.:Something distinguishable as an identifiable class based on common qualities.","longName":"C117062:C70793:C165683:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurement, Test or Examination Detail","conceptCode":"C117062","definition":"Particulars considered individually and in relation to a measurement, test or examination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical Study Sponsor","conceptCode":"C70793","definition":"An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Defined","conceptCode":"C165683","definition":"Clearly characterized or delimited.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D18DC466-3ACD-6745-E053-4EBD850AEA72","latestVersionIndicator":"Yes","beginDate":"2021-11-24","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-24","modifiedBy":"ONEDATA","dateModified":"2021-11-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D18DC466-3ADE-6745-E053-4EBD850AEA72","latestVersionIndicator":"Yes","beginDate":"2021-11-24","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-24","modifiedBy":"SOKKERL","dateModified":"2022-06-13","changeDescription":"11/24/2021 created for IFA form, wz.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Theradex-1","type":"Alternate Question Text","description":"Result type","url":null,"context":"Theradex"},{"name":"Laboratory test detail type","type":"Preferred Question Text","description":"Laboratory test detail type","url":null,"context":"Theradex"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D18DDD64-0914-6739-E053-4EBD850AFAD6","latestVersionIndicator":"Yes","beginDate":"2022-06-13","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-24","modifiedBy":"SOKKERL","dateModified":"2022-06-13","changeDescription":"11/24/2021 created for IFA form, wz.","administrativeNotes":"released QRTLY metrics. LS","unresolvedIssues":null,"deletedIndicator":"No"}}